Moody's assigns Endo notes B1

Moody's Investors Service said it assigned a rating of B1 to the new senior unsecured notes of Endo Finance Co., a wholly owned subsidiary of Endo Health Solutions Inc.

There are no changes to Endo's existing ratings, including the Ba3 corporate family rating, the Ba3-PD probability of default rating and the B1 senior unsecured rating.

The outlook remains negative.

Proceeds are expected to be to refinance Endo's existing credit facility, for fees and expenses related to Endo's pending acquisition of Paladin Labs Inc. and for general corporate purposes.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.